摘要
目的分析血塞通治疗冠心病心绞痛的临床疗效。方法80例冠心病心绞痛患者,根据患者入院顺序分为对照组和研究组,各40例。对照组患者采用常规药物治疗,研究组在常规基础上加用血塞通治疗。对比两组临床疗效及不良反应发生情况。结果研究组治疗总有效率为90.0%,明显高于对照组的60.0%,差异有统计学意义(P<0.05)。研究组不良反应发生率5.0%明显低于对照组的40.0%,差异有统计学意义(P<0.05)。结论针对冠心病心绞痛患者临床采用心内科常规治疗联合注射用血塞通效果明显,能够显著改善患者的临床症状,降低不良反应,应该给予大力的推广与应用。
Objective To analyze the clinical efficacy of Xuesaitong on angina pectoris of coronary heart disease.Methods A total of 80 patients with angina pectoris of coronary heart disease were divided into control group and research group according to admission order,with 40 cases in each group.The control group was treated with conventional drugs,and the research group was treated with Xuesaitong based on conventional drugs.The clinical efficacy and occurrence of adverse reactions were compared between the two groups.Results The total effective rate of treatment of the research group was 90.0%,which was obviously higher than 60.0%of the control group,and the difference was statistically significant(P<0.05).The incidence of adverse reactions 5.0%of the research group was obviously lower than 40.0%of the control group,and the difference was statistically significant(P<0.05).Conclusion Conventional treatment combined with Xuesaitong for injection shows obvious effect for patients with angina pectoris of coronary heart disease,which can significantly improve the clinical symptoms and reduce the occurrence of adverse reactions,which should be vigorously promoted and applied.
作者
祖玉莲
ZU Yu-lian(Department of Internal Medicine,Haicheng Orthopedic Hospital,Haicheng 114200,China)
出处
《中国实用医药》
2021年第2期121-123,共3页
China Practical Medicine
关键词
冠心病心绞痛
注射用血塞通
心内科规范治疗
Angina pectoris of coronary heart disease
Xuesaitong for injection
Standard treatment in Department of Cardiology
